期刊： EUROPEAN JOURNAL OF CANCER, 2023; 187 ()
Purpose: Unresectable, locally advanced sinonasal epithelial tumours are rare diseases with poor prognosis. Multimodal approach is widely used, althou......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 191 ()
Purpose: The safety and objective clinical responses were observed in the phase I study using adjuvant autologous tumour-infiltrating lymphocytes (TIL......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 194 ()
Background: The incidence of early-onset pancreatic cancer (EOPC) has risen dramatically in recent years. We aimed to characterise the clinical and ge......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 194 ()
Aim: Myoepithelial carcinoma occurs mainly in salivary glands but rarely can also occur in soft tissues or bone. In this paper, we evaluated the role ......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 182 ()
Introduction: Bone metastases (BM) in renal cell carcinoma (RCC) are associated with a poor prognosis based on retrospective studies evaluating antian......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 186 ()
Objective: Quality of surgery is essential for survival in gastric adenocarcinoma, but studies examining surgeons' proficiency gain of gastrectomies a......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 188 ()
Background: Germline pathogenic variants (PVs) in BRCA1/2 genes are asso-ciated with breast cancer (BC) risk in both women and men. Multigene panel te......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 189 ()
Background: Early metastatic relapse of triple-negative breast cancer (mTNBC) after anthracyclins and/or taxanes based (A/T) primary treatment represe......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 189 ()
Background: The clinical value of an expert pathological review in patients with an atypical melanocytic lesion diagnosis remains unclear. Herein, we ......
期刊： EUROPEAN JOURNAL OF CANCER, 2023; 190 ()
Background: The PanaMa trial demonstrated significant benefit in progression-free survival with the addition of panitumumab (Pmab) to fluorouracil and......
